BRIEF published on 06/05/2026 at 22:20, 11 days 23 hours ago Monthly publication of Nanobiotix voting rights Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
BRIEF published on 06/02/2026 at 22:35, 14 days 22 hours ago Nanobiotix: Review of the first quarter of 2026 Biotechnology Clinical Trials Capital Increase Nanotechnology NBTXR3
BRIEF published on 06/02/2026 at 22:35, 14 days 22 hours ago Nanobiotix Reports Q1 2026 Operational and Financial Progress NSCLC Financial Update NANOBIOTIX JNJ-1900 AACR 2026
PRESS RELEASE published on 06/02/2026 at 22:30, 14 days 22 hours ago Nanobiotix Provides First Quarter 2026 Operational and Financial Update Nanobiotix provides operational and financial update for Q1 2026, including successful fundraising and clinical study advancements in cancer treatment Cancer Treatment Clinical Study Financial Update NANOBIOTIX Q1 2026
BRIEF published on 06/02/2026 at 08:35, 15 days 12 hours ago Nanobiotix joins the Euronext Tech Leaders index Innovation Investors Biotechnology NANOBIOTIX Euronext Tech Leaders
BRIEF published on 06/02/2026 at 08:35, 15 days 12 hours ago Nanobiotix Joins Euronext Tech Leaders Index Innovation Biotechnology Healthcare NANOBIOTIX Euronext Tech Leaders
PRESS RELEASE published on 06/02/2026 at 08:30, 15 days 12 hours ago Nanobiotix Joins the Euronext Tech Leaders Index Nanobiotix joins the Euronext Tech Leaders Index, a move recognizing its contributions to nanotechnology in healthcare innovation and expanding treatment options for cancer patients Cancer Treatment Healthcare Innovation Nanotechnology NANOBIOTIX Euronext Tech Leaders Index
BRIEF published on 05/26/2026 at 23:04, 21 days 22 hours ago NANOBIOTIX Completes Global Offering with $100 Million Proceeds Securities Biotechnology Investment Global Offering NANOBIOTIX
PRESS RELEASE published on 05/26/2026 at 22:59, 21 days 22 hours ago NANOBIOTIX Announces Closing of Global Offering Nanobiotix closes global offering with total gross proceeds of $100 million. Proceeds to fund development and corporate purposes. Ordinary shares and ADSs issued Development ADSs Proceeds Global Offering NANOBIOTIX
BRIEF published on 05/22/2026 at 22:20, 25 days 23 hours ago NANOBIOTIX raises $100 million through a global offering Biotechnology Fundraising Ads Cancer NANOBIOTIX
Published on 06/17/2026 at 16:55, 4 hours 29 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/17/2026 at 16:45, 4 hours 39 minutes ago Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean
Published on 06/17/2026 at 14:30, 6 hours 54 minutes ago Solitario Advances 2026 Ponderosa Drilling Program
Published on 06/17/2026 at 14:00, 7 hours 24 minutes ago CHAR Tech Reminds Shareholders of June 18 Investor Update Call
Published on 06/17/2026 at 19:10, 2 hours 14 minutes ago Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:40, 2 hours 44 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2026 at 18:36, 2 hours 48 minutes ago BILENDI: Bilendi announces that Euroland Corporate has initiated coverage of its shares
Published on 06/17/2026 at 18:23, 3 hours 1 minute ago EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Conclusion of a delisting agreement with Bayerische Gewerbebau AG
Published on 06/17/2026 at 18:05, 3 hours 19 minutes ago WACACO LAUNCHES PRESTINA, A PATENTED MANUAL COFFEE BREWER THAT TURNS THE CUP INTO THE PRESS
Published on 06/17/2026 at 17:40, 3 hours 44 minutes ago Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 12 hours 39 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 9 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 1 day 22 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 2 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
